Skip to main content
Premium Trial:

Request an Annual Quote

QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel

NEW YORK ─ QuantuMDx on Thursday announced it is launching a respiratory panel, the Q-POC SARS-CoV-2, Flu A/B & RSV Assay, after obtaining CE marking.

The panel, which tests for flu, respiratory syncytial virus, and SARS-CoV-2, expands QuantuMDx's menu for the Q-POC platform and builds on the capabilities of the Q-POC SARS-CoV-2 test launched in 2021, providing rapid molecular testing in clinical and nonclinical settings, the firm said.

The PCR-based respiratory panel provides a differential diagnosis, enabling rapid triage and effective treatment strategies, including for at-risk groups of patients, the firm said, adding that testing is completed in approximately 30 minutes at the point of need.

QuantuMDx noted that early identification of co-infection is particularly important in at-risk groups and can help to shorten treatment as well as hospital stays, lowering overall costs.

"The system offers a simple one-sample, one-test process … which can be operated by any healthcare professional after basic training, differentiating it from many competitor models on the market," Jonathan O’Halloran, CEO of QuantuMDx, said in a statement. "With the coming winter likely to bring parallel pressure from these viruses, on-demand rapid accurate PCR testing … has the potential to provide clinicians with an optimum solution for respiratory infection control."

Newcastle Upon Tyne, UK-based QuantuMDx said a future version of the Q-POC platform will include a microarray to further expand its multiplexing capabilities and enable large syndromic and antimicrobial resistance mutation panels.

Last November, the firm announced it had obtained a £15 million ($20.3 million) equity investment from Vita Spring IVD Fund, a Hong Kong-based venture capital firm, to expand the development of its Q-POC PCR platform.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.